This alert is to inform healthcare professionals that VYXEOS , the first fixed-combination liposomal formulation of DAUNO rubicin and cytarabine approved by the US Food and Drug Administration (FDA) this month, is different from other single entity DAUNO rubicin and cytarabine products that are...
Resource Library
Whether you have experienced a medication error in your organization or you are proactively implementing prevention strategies, you are not alone. Thousands of organizations worldwide have relied on ISMP's resources for institutional change to reduce errors on a daily basis. These resources are developed from ISMP's review of reports through its national error reporting programs, peer-reviewed articles in its publications, and/or consensus gathering summits on topics pertinent to specific errors or hazards. ISMP offers a wide range of downloadable and easy to use resources. Many are free.
Featured
All Resources
The latest annual report of ISMP’s QuarterWatch™ analyzes more than 1.2 million new adverse drug event reports submitted to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) during 2016. Part I of this newsletter feature, which appeared in the July 13, 2017 issue,...
The latest issue of ISMP’s QuarterWatch™ is an annual report that focuses on drugs and specific adverse events that affect large populations and involve substantial numbers of serious injuries reflected in 1.2 million reports submitted to the US Food and Drug Administration (FDA) Adverse Event...
The debate regarding whether healthcare providers should be allowed to send orders via text messages continues in healthcare. Technology-savvy healthcare professionals have embraced the convenience and usefulness of this 21st century form of communication, while opponents feel it is too informal to...
Problem: Some patients may require a medication in a dose or dosage form that is not commercially available. Such medications must be specially compounded for the patient in a pharmacy. As part of an ongoing collaboration with a provincial death investigation service, our sister organization, ISMP...
An intravenous (IV) line mix-up in a hospital reoccurred within a few months despite what was thought to be an effective action plan after the initial event. After the first event, an interdisciplinary team had conducted a thorough investigation, identified the causal factors, and developed an...
In January 2017, we invited readers of our acute care, community/ambulatory care, long-term care, and nursing newsletters to complete an online survey to learn about the use of verbal orders that are spoken aloud (face-to-face), provided via telephone, or left on voicemail. The survey directed...
Problem: Certain medical devices may be manually or commercially coated with heparin to negate the aggressive biological response that occurs when blood contacts a foreign surface. These biological responses, which can have an adverse effect on device performance and the patient’s well-being,...
The latest issue of ISMP’s QuarterWatch™ provides a review of drug safety issues reflected in adverse drug events reported to the US Food and Drug Administration (FDA) during the third quarter (Q3) of 2016 and during the previous 12 months. In this report, we examine depression and suicidal thoughts...